Want to see SG:AP4 full AI Analyst Report?
AP4 Stock Chart & Stats
S$0.90
-S$0.03(-2.73%)
At close: 4:00 PM EST
S$0.90
-S$0.03(-2.73%)
Day’s Range― - ―
52-Week RangeS$0.66 - S$0.99
Previous CloseN/A
Volume1.45M
Average Volume (3M)4.77M
Market Cap
S$1.26B
Enterprise ValueS$3.37B
Total Cash (Recent Filing)S$630.25M
Total Debt (Recent Filing)S$0.00
Price to Earnings (P/E)20.5
Beta0.45
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.7%
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,484,904,000
10 Day Avg. Volume8,088,999
30 Day Avg. Volume4,774,049
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)2.76
Price to Sales (P/S)4.24
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
S$1.00Price Target Upside11.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.13
Revenue Forecast (FY)S$1.02B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthNear-zero leverage gives the company long-term financial flexibility to fund operations, sustain dividends, support buybacks or pursue opportunistic M&A without stressing cash flow. Low debt materially reduces bankruptcy risk and improves resilience across cycles.
Free Cash Flow GenerationConsistent, growing free cash flow supports durable shareholder returns and internal reinvestment. FCF generation funds capex and dividends without reliance on external financing, underpinning capital allocation flexibility and structural ability to withstand revenue volatility.
Sustained ProfitabilityHigh mid-teens ROE and robust 2025 margins indicate enduring earnings power and operational leverage in the core medical instruments business. Strong margins provide buffers for reinvestment and dividend maintenance even if top-line growth is uneven.
Bears Say
Revenue DeclineA recent drop in revenue signals weaker demand or loss of momentum which can persist if structural growth drivers are absent. Prolonged top-line contraction would erode operating leverage, reduce reinvestment capacity, and pressure long-term cash generation and returns.
Margin Compression Vs. PeakThe material reduction from prior peak margins lowers long-run earnings potential and narrows the company's margin cushion against cost inflation or pricing pressure. Persistent compression could limit ability to fund growth, dividends, or strategic initiatives.
Earnings Quality / Cash ConversionFCF below net income and cyclical cash flow volatility raise a structural earnings-quality concern. If cash conversion stays below accounting profits, management may face constraints on sustainable dividends and investments during downturns, limiting strategic optionality.
Riverstone Holdings News
AP4 FAQ
What was Riverstone Holdings Limited’s price range in the past 12 months?
Riverstone Holdings Limited lowest share price was S$0.66 and its highest was S$0.98 in the past 12 months.
What is Riverstone Holdings Limited’s market cap?
Riverstone Holdings Limited’s market cap is S$1.26B.
When is Riverstone Holdings Limited’s upcoming earnings report date?
Riverstone Holdings Limited’s upcoming earnings report date is Aug 06, 2026 which is in 31 days.
How were Riverstone Holdings Limited’s earnings last quarter?
Riverstone Holdings Limited released its earnings results on May 08, 2026. The company reported S$0.009 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.009.
Is Riverstone Holdings Limited overvalued?
According to Wall Street analysts Riverstone Holdings Limited’s price is currently Undervalued.
Does Riverstone Holdings Limited pay dividends?
Riverstone Holdings Limited pays a Notavailable dividend of S$0.016 which represents an annual dividend yield of 8.7%. See more information on Riverstone Holdings Limited dividends here
What is Riverstone Holdings Limited’s EPS estimate?
Riverstone Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Riverstone Holdings Limited have?
Riverstone Holdings Limited has 1,484,904,000 shares outstanding.
What happened to Riverstone Holdings Limited’s price movement after its last earnings report?
Riverstone Holdings Limited reported an EPS of S$0.009 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.795%.
Which hedge fund is a major shareholder of Riverstone Holdings Limited?
Currently, no hedge funds are holding shares in SG:AP4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Riverstone Holdings Stock Smart Score
Company Description
Riverstone Holdings Limited
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.
AP4 Stock 12 Month Forecast
Average Price Target
S$1.00
▲(11.11% Upside)
Technical Analysis
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
Aoxin Q&M Dental Group Ltd.
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Options Prices
Currently, No data available
---







